Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report
By
Thien-Chong Marcus Wong
Yizhi Ong
June 29, 2026
Clinical Scorecard: Application of Topical Recombinant Collagen After Fractional Radiofrequency Microneedling for Non-Invasive Facelift: A Case Study
At a Glance
Category Detail
Condition Fractional Radiofrequency Microneedling (FRM) Key Mechanisms Induces microinjury to stimulate neocollagenesis and elastin production. Target Population Adults with facial laxity, specifically females with Fitzpatrick skin type IV. Care Setting Clinical aesthetic procedures.
Key Highlights
Topical recombinant collagen applied post-FRM showed early reduction in erythema and edema. Patients reported immediate relief from discomfort after collagen application. No adverse events or side effects were reported in the case study. Guideline-Based Recommendations
Diagnosis
Assessment of facial laxity and skin type prior to FRM. Management
Application of topical recombinant collagen immediately post-FRM. Monitoring & Follow-up
Observe for erythema, edema, and patient-reported discomfort post-treatment. Risks
Common postprocedural effects include erythema, edema, bruising, and discomfort. Patient & Prescribing Data
Two 40-year-old female patients with mild-to-moderate facial laxity.
Topical recombinant collagen may enhance recovery post-FRM.
Clinical Best Practices
Document clinical photography before and after treatment for assessment. Consider patient-reported outcomes in post-treatment evaluations. Related Resources & Content
